Preclinical Characterization of RSM-932A, a Novel Anticancer Drug Targeting the Human Choline Kinase Alpha, an Enzyme Involved in Increased Lipid Metabolism of Cancer Cells
FI: 5,683
Type: Article
Artículo original
Year: 2015
Writers
Lacal, JC; Fields, JM
Magazine
Title: MOLECULAR CANCER THERAPEUTICS
Quartile
- Q1